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Background: Unintended pregnancy is a public health problem and unmet medical need 
worldwide. It is estimated that in the year 2012, almost 213 million pregnancies occurred, and 
the global pregnancy rate decreased only slightly from 2008 to 2012. It was also estimated that 
85 million pregnancies (40% of all pregnancies) were unintended and that 38% ended in an 
unintended birth.
Objectives: To assess knowledge and attitudes of Latin American (LA) obstetricians and 
gynecologists (OBGYNs) regarding unintended pregnancies and aspects of combined oral 
contraceptive (COC) use.
Methods: A survey was conducted during a scientific meeting about contraception in 2014, 
in which OBGYNs from 12 LA countries who provide attention in contraception were invited 
to respond to a multiple-choice questionnaire to assess their knowledge and attitudes regarding 
unplanned pregnancy and some aspects regarding COC use.
Results: A total of 210 OBGYNs participated in the study. Their knowledge regarding COC 
failure was low. The participants reported they believed that their patients habitually forgot to 
take a pill and that their patients did not know what to do in these situations. They were aware 
of the benefits of COC use; however, they were less prone to prescribe COCs for the purpose 
of protecting against ovarian and endometrial cancer, and one-quarter of them had doubts about 
the association between COC use and cancer risk.
Conclusion: The interviewed LA OBGYNs showed some flaws in terms of knowledge of COC 
failure rates and the non-contraceptive benefits and risks of COCs. To adequately counsel their 
patients regarding COC intake, OBGYNs must be updated regarding all aspects of COC use.
Keywords: contraception, unintended pregnancy, benefits of oral contraceptives
Introduction
Unintended pregnancy is a public health problem worldwide, both in developing and 
developed countries, that may pose burdens on children, women, men, and families, 
and contribute to maternal, infant, and child mortality. Also, it is responsible for a 
percentage of unsafe abortion in countries in which abortion is not legal as in most 
Latin American (LA) countries.1 It is estimated that in the year 2012, almost 213 million 
pregnancies occurred, and the global pregnancy rate decreased only slightly from 2008 
to 2012.2 It was also estimated that 85 million pregnancies (40% of all pregnancies) 
were unintended and that 38% ended in an unintended birth.2,3
A study that evaluated pregnancy rates by intention and outcome showed a world-
wide decline of 17% of unintended pregnancy in both developed and developing 
countries from 1995 to 2008. Also, in 2008, a worldwide estimate showed that four 
out of ten pregnancies were unintended, with a higher proportion in South American 
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countries and south Saharan Africa, where six in ten pregnan-
cies were unintended.2,3
Family planning programs have an important role in 
the reduction of unintended pregnancies. The prevention 
of unintended pregnancies is a cost-effective strategy for 
health services,4 and it depends on coordinated actions on 
various fronts. It is desirable that governments take action 
to improve reproductive health services, including efficient 
family planning programs that offer contraceptive methods 
at an affordable cost, having adequate facilities, and training 
health care professionals (HCPs) in family planning, among 
other initiatives. HCPs play an important role in the reduc-
tion of the rate of unintended pregnancies, and this role is 
influenced by the knowledge, attitudes, and myths of these 
professionals regarding contraceptive methods.
 Presently, there is no doubt that long-acting reversible 
contraceptives (intrauterine contraceptives and implants) 
have a higher contraceptive efficacy than combined oral 
contraceptives (COCs), vaginal rings, or patches5,6 because 
shorter-acting methods are user-dependent. The contracep-
tive efficacy for typical use is higher than for perfect use 
because daily or periodic attention of the user is required.5 
Nevertheless, COCs are the first contraceptive that many 
women use after sexual debut and the main contraceptive 
option in many settings, with a prevalence of almost 25% in 
several LA countries.7 The use of any contraceptive method 
is influenced by both patients’ and doctors’ fears, myths, 
and misperceptions. Furthermore, knowledge regarding 
the risks is frequently higher than knowledge regarding the 
benefits among HCPs and women.8 In a Brazilian study, 
obstetricians and gynecologists (OBGYNs) reported that 
women frequently were afraid that hormone intake could 
affect their body, provoke infertility, increase weight, and in 
general were worried that hormones could affect their health.9 
Furthermore, in a Canadian-based study, it was reported that 
52% of the interviewed women indicated that they did not 
know what HCPs advised about the use of COC and the risk 
of uterine and ovarian cancer.10
It is important that OBGYNs and other HCPs are aware 
of the updated scientific information regarding contraceptive 
methods because better-informed HCPs are able to transmit 
correct information to users and potential users and, conse-
quently, improve the quality of typical use. This study was 
conducted with the objective of assessing the knowledge and 
attitudes of a group of LA OBGYNs regarding unintended 
pregnancies and some aspects of the use and prescription 
of COCs.
Material and methods
Design
The study was conducted in the second quarter of 2014, dur-
ing a scientific meeting in Chile that was specifically designed 
to provide information about contraceptive methods. All the 
participants were OBGYNs from 12 LA countries (Argentina, 
Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, 
Guatemala, Mexico, Paraguay, Peru, and Venezuela) 
who provided regular consultation in contraception in their 
clinical practice. The study protocol received approval 
from the Ethical Committee of the University of Campinas, 
Brazil. The objectives of the study and the voluntary nature 
of participation were explained to all the participants in the 
meeting, making it clear that by answering the questions, 
the OBGYNs were consenting to participate in the study. 
This procedure for obtaining consent was approved by the 
Ethical Committee.
Data collection
All the participants in the meeting were invited to respond 
to a multiple-choice questionnaire through an electronic 
system during the meeting at the end of each lecture. The 
questionnaire was designed to provide demographic infor-
mation regarding the nationality, age, sex, training, and 
clinical experience in family planning of the participants. 
After characterization data were collected, the participants 
provided feedback on the lectures that they attended during 
the meeting. For this manuscript, the questions selected were 
related to unintended pregnancy worldwide and knowledge 
about some aspects of COCs, such as COC use and the risk 
of venous thromboembolism (VTE) and the risk of several 
cancers.
The questions were developed specifically for this study 
by the researchers and reviewed by an expert group of LA 
OBGYNs who did not participate in the meeting. The par-
ticipants who agreed to take part in the study were provided 
with electronic keypads to answer the multiple-choice ques-
tionnaire. There were five questions for each issue, and five 
answer options based on the contents of each lecture. The 
questions on each theme had to be completed in ~3 minutes 
because after that time period, the system automatically 
blocked the ability to answer. After that, the system provided 
the audience with the response percentage for each question. 
One of the authors coordinated the explanation of the survey, 
as well as the distribution and collection of the electronic 
keypads. To guarantee anonymity, the keypads were only 
identified with a number.
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Data analysis
Initially, a descriptive simple analysis was performed on 
the dependent variable to examine the knowledge, attitudes, 
and practices regarding unintended pregnancy and COC 
use. Then, dependent variables were evaluated, taking into 
account age (49 years, 50 years), sex (male/female), and 
the sector in which the OBGYN worked (exclusively public, 
both private and public). The statistical tests used, according 
to the data obtained, were the Pearson’s χ2, Yates’ χ2, and 
Fisher’s exact tests. The software used was SPSS v20.0. The 
significance was established at P0.05.
Results
The total number of the OBGYNs participating in the meet-
ing was 210, and the number of respondents to each ques-
tion ranged from 153 (72.8%) to 191 (90.9%). The mean 
(± standard deviation) age of the OBGYNs who partici-
pated in the survey was 48.7±10.6 years (ranged from 30 to 
72 years). Eighty-eight (41.9%) were female, and 122 (58.1%) 
were male. Practicing only in the public sector was reported 
by five (2.4%), OBGYNs practicing only in the private sector 
was reported by 81 (38.6%), and practicing in both the public 
and private sectors was reported by 112 (55.3%).
awareness about unplanned pregnancies
When the OBGYNs were asked about the prevalence of 
unintended pregnancies, most of them answered that African 
countries have the highest rate, followed by LA countries, 
with the exception of OBGYNs who worked in both the 
public and private sectors. The majority of these physicians 
responded that the rate in LA countries was similar to those 
in other developing countries. Furthermore, the majority of 
the OBGYNs, independent of age or sex, reported that the 
incidence of unintended pregnancy is higher among ado-
lescents and that it has a social impact. Also, the OBGYNs 
were asked why women had elective abortions, and the 
majority answered that most of the women who had elective 
abortions did so because they did not use contraception or 
had used it incorrectly (Table 1). No significant differences 
were observed regarding age, sex, or the sector in which the 
OBGYN worked.
Knowledge and attitudes about cOcs
The second group of questions related to knowledge about 
some aspects of COC use. Only ~50% of the HCPs were 
aware of COC failure rates given typical use, and those who 
were younger, were female, and worked in the public sector 
were more accurate regarding this figure. According to ~50% 
of the interviewed HCPs, ~30% of COC users forget at least 
one pill, and ~45% of the HCPs reported that women do not 
know what to do when they forget to take a pill (Table 2). 
Only the age variable of the OBGYN (50 years old) signifi-
cantly affected the answer regarding the proportion of women 
using COCs who forget to take them (P0.046).
Table 1 Questions and answers regarding unintended pregnancies
Age (%) Sex (%) Working in (%)
49 years 50 years Female Male Public  
sector
Private/public 
sector
Unintended pregnancy rates are (n=191):
similar in la to developed countries 5.6 8.0 4.5 8.2 8.2 5.4
similar in la to developing countries 31.5 26.0 31.8 27.9 24.5 33.9
The highest worldwide in la 25.9 24.0 29.5 21.3 20.4 28.6
The highest worldwide in africa 37.1 42.0 34.1 42.5 47.0 32.2
Unintended pregnancy is more common among (n=190):
adolescents 79.5 66.7 69.2 66.1 76.8 69.7
Young adults 12.3 19.3 20.0 13.5 9.0 22.4
all women 8.2 14.0 10.8 10.4 14.3 7.9
Unintended pregnancy has a social impact (n=190):
Yes 97.2 98.4 100.0 96.1 100.0 96.2
no 2.8 1.6 0.0 3.9 0.0 3.8
In your opinion, regarding the women who opt for an abortion (n=191):
Most do not use a contraceptive 54.3 58.6 58.3 54.3 61.8 52.0
Most use a contraceptive incorrectly 44.3 36.2 41.7 40.0 32.7 46.7
Most use a fertility awareness method  
or were victims of sexual abuse
1.4 5.2 0.0 5.7 5.5 1.3
Abbreviation: la, latin american.
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Furthermore, the OBGYNs were asked if women were 
aware of the non-contraceptive benefits of COC use, and most 
of the respondents answered that less than 20% were aware of 
these benefits. They also reported that their patients are seek-
ing dysmenorrhea and premenstrual syndrome (PMS) relief, 
the reduction of acne and hirsutism, no weight increase, and 
a reduction in both bleeding flow and number of menstrual 
cycles in equal numbers. Additionally, the HCPs reported that 
dysmenorrhea and the relief of PMS, as well as a reduction 
of acne and hirsutism, are the main benefits they considered 
when prescribing COCs (Table 3). Again, no significant 
differences were observed regarding age, sex, or the sector 
in which the OBGYN worked.
Regarding the block of questions about VTE and cancer 
risk related with COC use, it was observed that almost all of the 
HCPs were aware of the VTE risk associated with COCs. How-
ever, most of them were not aware of the relationship between 
the length of COC use and the risk of VTE, although most of 
the respondents were aware of the incidence of VTE among 
COC users. Finally, between 12% and 25% of the respondents 
had doubts about the relationship between COC use and cancer 
risk, with no significant differences regarding age, sex, or the 
sector in which the OBGYN worked (Table 4).
Discussion
It is estimated that in developed countries, unintended preg-
nancies accounted for more than 40% of pregnancies,11–13 
and at least one-third of the ~180 million pregnancies that 
occur annually in developing countries are unintended.13 
In many settings, unintended pregnancies are a consequence 
of the high cost of contraceptives, poor knowledge among 
women regarding contraception, inadequate distribution of 
contraceptives, myths (mainly associated to hormonal con-
traceptives and intrauterine contraceptives), a lack of HCPs 
available to provide this kind of service, or a lack of HCP 
training regarding the provision of contraceptives, mainly for 
those that require the active participation of a HCP, such as 
long-acting reversible contraceptive methods.6,14,15
Unintended pregnancies commonly end in elective abor-
tion, and in most of the LA countries, abortion is not legal. 
Therefore, the procedure has frequent health consequences, 
and when it is available, it is only available in a restricted 
manner.13 The OBGYNs interviewed in this study stated 
that women who opt for abortion often either did not use or 
incorrectly used contraceptive methods.
Furthermore, many unintended pregnancies occur due to 
contraceptive failure. In the case of COC use, although the 
Table 2 Questions and answers regarding some aspects of use of cOcs
Age (%) Sex (%) Working in (%) P-value
49 years 50 years Female Male Public  
sector
Private/public 
sector
Failure rate of cOc given typical use (n=175):
1%–2% 32.5 34.4 38.0 30.0 32.7 34.5
4% 16.2 24.1 11.1 27.1 17.3 21.0
8% 31.1 29.3 28.6 31.4 32.7 28.4
10% 20.3 12.1 22.2 11.4 17.3 16.0
according to the OBgYns, the proportion of women using cOcs who recognize forgetfulness (n=153): 0.046
5%–10% 9.8 27.0 23.4 12.5 16.0 18.7
30% 49.3 42.9 42.2 51.4 46.0 47.7
50% 23.9 20.6 20.3 23.6 26.0 19.8
70% 16.9 9.5 14.1 12.5 12.0 14.0
according to the OBgYns the proportion of women who recognize they forget at least one cOc pill per month (n=173):
30% 49.3 50.8 54.1 47.8 53.8 48.7
50% 39.1 32.2 37.7 33.3 34.6 35.9
70% 8.7 10.2 6.6 11.6 11.5 7.7
90% 2.8 6.8 1.6 7.2 0.0 7.7
according to OBgYns, if women forget to take a pill (n=175):
They know what to do  
when they forget 2–3 pills
29.7 15.8 22.0 23.8 17.7 26.0
They understand the  
instructions
14.0 19.3 17.0 15.9 13.3 18.2
They follow the instructions 17.2 14.0 20.3 11.1 20.0 13.0
They do not know what  
to do
39.1 50.9 40.7 49.2 48.9 42.9
Abbreviations: cOc, combined oral contraceptive; OBgYns, obstetricians and gynecologists.
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Table 3 Questions and answers about benefits of COCs
Age (%) Sex (%) Working in (%)
49 years 50 years Female Male Public  
sector
Private/public 
sector
According to the OBGYNs, women are aware of non-contraceptive benefits of COC (n=187):
less than 20% 61.1 72.2 62.2 71.4 79.3 58.1
Between 40%–50% 22.2 16.7 24.3 14.3 10.3 25.6
almost 75% 13.9 8.3 8.1 14.3 6.9 14.0
all women 2.8 2.8 5.4 0.0 3.4 2.3
When OBGYNs prescribe a COC, which non-contraceptive benefits influenced the decision? (n=187):
Improve dysmenorrhea and PMs 53.0 77.2 64.7 66.6 64.3 66.7
reduce acne and hirsutism 46.9 22.9 35.3 33.3 35.7 33.0
reduce ovarian/endometrial cancer risk 0.0 0.0 0.0 0.0 0.0 0.0
Which non-contraceptive benefits are your patients looking for when they procure a COC? (n=190):
Improve dysmenorrhea and PMs 27.8 21.6 28.2 20.6 30.0 20.9
reduce acne and hirsutism 25.0 21.6 20.5 26.5 26.7 20.9
Prevent weight increase 22.2 37.8 30.8 29.4 30.0 30.2
Reduce bleeding flow and number of cycles 25.0 18.9 20.5 23.5 13.3 27.9
Abbreviations: cOc, combined oral contraceptive; OBgYn, obstetrician and gynecologist; PMs, premenstrual syndrome.
Table 4 Questions and answers about risks associated with cOc use
Age (%) Sex (%) Working in (%)
49 years 50 years Female Male Public  
sector
Private/public 
sector
Main risk for VTe and cOc use (n=184):
Familiar history of VTe 0.0 3.1 0.0 1.9 0.0 1.6
35 years old 0.0 1.6 0.0 1.9 0.0 1.6
Personal history of VTe 0.0 0.0 25.0 17.0 26.5 17.5
smoking 0.0 0.0 0.0 3.8 0.0 3.2
Obesity 2.6 7.8 4.5 1.9 0.0 4.8
all 97.4 87.5 70.5 73.6 73.5 71.4
Which statement about COC use and VTE is incorrect? (n=184):
The risk is high within the first months of use 2.3 0.0 0.0 1.9 2.9 0.0
The risk increases after a pause of 4 weeks in use 18.2 14.6 23.1 11.3 20.6 13.8
The risk is independent of the length of use 63.6 64.2 66.7 52.8 47.1 66.5
The risk is high with high estrogen levels 9.1 12.5 5.1 15.1 14.7 8.6
The role of progestin is still controversial 6.8 18.8 5.1 18.9 14.7 12.1
The incidence of VTe among cOc users is (n=173):
4/10,000 women/year 1.8 16.7  6.1 11.5 9.3 9.0
9–11/10,000 women/year 90.9 83.3 89.8 85.2 81.4 91.0
15–20/10,000 women/year 5.5  0.0  2.0 3.3 7.0 0.0
21–29/10,000 women/year 1.8  0.0  2.0 0.0 2.3 0.0
according to the OBgYns, the use of cOcs could increase the incidence of cancer of (n=184):
endometrium 2.8 5.9 5.3 2.9 0.0 7.3
cervix 83.3 61.8 78.9 64.7 71.0 73.2
colorectal 0.0 2.9 2.6 2.9 0.0 4.9
all of them 0.0 5.9 0.0 5.9 3.2 2.4
I have doubts 13.9 23.5 13.2 23.5 25.8 12.2
Abbreviations: cOc, combined oral contraceptive; OBgYn, obstetrician and gynecologist; VTe, venous thromboembolism.
contraceptive is highly effective given perfect use (consistent 
and correct), its effectiveness is lower given typical use, 
mainly due to the fact that its efficacy is dependent on daily 
attention and that women frequently forget one or more pills 
during the cycle intake.16–19
Our survey showed that almost 50% of the participat-
ing OBGYNs did not know the failure rate for COCs given 
typical use, although almost 90% of the OBGYNs responded 
that between 30% and 70% of their patients forget to take at 
least one pill per cycle, and almost 50% reported that COC 
International Journal of Women’s Health 2015:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
490
Bahamondes et al
users do not know what to do when they forget a pill. Any 
system that may help women to not forget their pill intake 
is welcome.
Most of the participants reported that less than 20% of 
COC users are aware of the non-contraceptive benefits of the 
method. Furthermore, the benefits the interviewed OBGYNs 
were interested in when they prescribed COCs were in gen-
eral similar to those they reported that women were seeking. 
The non-contraceptive benefits that the OBGYNs reported 
are well-known and supported by scientific evidence only 
for some COC preparations.20–22 It is already well-established 
that not all of the COCs currently on the market improve 
dysmenorrhea or PMS, and that not all of them reduce acne 
or hirsutism.20–22 Regarding weight gain and hormonal con-
traceptive use, there is a large body of evidence that weight 
gain is associated with lifestyle and is not associated with 
contraceptive intake.23
In our survey, none of the OBGYNs reported that they 
prescribe COCs with the aim of reducing ovarian or endo-
metrial cancer, and almost one-quarter reported doubts about 
the cancer prevention benefits of COC use. This was more 
common among older male OBGYNs working in the public 
sector. The use of COCs has been associated with a protective 
effect against ovarian and endometrial cancer, and it is esti-
mated that the reduction is ~50% for 15 years of use. Although 
the protective effect declines as time passes, a significant 
effect was observed even a long time after the cessation of 
use. For endometrial cancer, the relative risk reduction is 
estimated at ~70% for 12 years of use, with a decrease upon 
further use. Even after discontinuing the use of COCs, the 
risk only begins to rise 20 years after last use.24
A recent US-based study25 conducted with 236 OBGYNs 
and family practitioners, of whom 93.6% prescribed hormonal 
contraceptives, assessed knowledge about hormonal contra-
ceptives and cancer prevention. This study showed that 73.6% 
of the respondents were aware of the decreased risk of endo-
metrial cancer with COC use and the increased risk among 
obese patients (95.5%). However, only 36.8% consistently 
counseled their patients regarding obesity-associated cancer 
risk. Furthermore, 51.5% of the OBGYNs reported ovarian or 
endometrial cancer prevention as a benefit of COCs use and 
were likely to identify risk factors associated with endometrial 
cancer. In that study, OBGYNs did not commonly prescribe 
COCs for ovarian and endometrial cancer prevention.
The OBGYNs that participated in the present survey 
were aware of the incidence and risk factors associated with 
COC use, including VTE; nevertheless, most of them were 
not aware of the fact that the risk is higher during the first 
months of use and declines significantly with continuous 
use.26–27 VTE is one of the main risks associated with COC 
use; however, its incidence during COC use is lower than 
during pregnancy and puerperium.
It is imperative that OBGYNs understand the benefits 
and risks of hormonal and non-hormonal contraceptive use 
because well-informed HCPs are able to translate this scientific 
knowledge for their patients and increase the acceptability, 
continuation, and effective use of contraceptives that require 
daily or periodical attention, such as COCs; furthermore, 
HCPs can help patients to overcome common myths and 
misconceptions.8–10
The role of OBGYNs in COC use is very important 
because counseling is crucial for adherence and correct use. 
Counseling must be a constant activity, one that is not only 
performed during the initial period of contraceptive use, in 
order to inform women about potential and expected side 
effects and non-contraceptive benefits. It is also crucial to 
adopt a new contraceptive method with at least the same 
contraceptive efficacy immediately after the discontinuation 
of an old one. It is important that HCPs, mainly OBGYNs 
and family practitioners, are aware of the low risk and high 
benefits of the use of many contraceptive methods. COCs 
are not the exception in this regard.
Conclusion
Our survey showed that the interviewed LA OBGYNs cor-
rectly identified unintended pregnancy as an important health 
issue. Regarding COCs, they reported that a percentage of 
their patients frequently forget to take a pill and that women 
habitually do not know what to do in the case of missed pills. 
They were not prone to prescribe COCs to reduce the risk 
of ovarian and endometrial cancer, and almost one-quarter 
had doubts about the association between pill intake and 
the risk of cancer development. OBGYNs should counsel 
their patients regarding the various aspects of COC intake, 
such as what to do in case of missed pills, risks, and non-
contraceptive benefits. In order to provide adequate counsel-
ing, it is necessary that OBGYNs be updated regarding all 
aspects of COC use. Despite the small sample size for a big 
region like LA, there are some concerns about the knowledge 
regarding COCs of this sample of OBGYNs. Our results 
could be useful to medical schools, scientific societies, and 
national and regional policy makers to increase a continued 
medical education in this matter, as well as to improve the 
use of existing national family planning guidelines and the 
World Health Organization guidelines about contraceptive 
methods.28,29
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